🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase III, open label, randomized controlled multi-center global ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-07-24
Trial ID
NCT03529084
Treatments Being Tested
The aim of this trial is to identify the maximum tolerated dose (MTD)/recom...
Status
Completed
Location
University Hospital of Cologne
Start Date
2018-04-25
Trial ID
NCT03516214
Treatments Being Tested
The study purpose is to evaluate the safety, tolerability, and preliminary ...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2018-01-29
Trial ID
NCT03333343
Treatments Being Tested
The purpose of this study is to assess long-term safety and provide continu...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2017-08-23
Trial ID
NCT03040973
Treatments Being Tested
The purpose of this first in human (FIH) trial was to characterize the safe...
Status
Terminated
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2017-05-26
Trial ID
NCT03114319
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2017-10-31
Trial ID
NCT03292133
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center SC-3
Start Date
2016-08-23
Trial ID
NCT02900664
To determine the efficacy and safety of nivolumab in combination with EGF81...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center Thoractic Head/Neck Med.Onc(2)
Start Date
2015-02-09
Trial ID
NCT02323126
This is a Phase I/II, multi-center, open-label study, composed with a Phase...
Status
Completed
Location
Massachusetts General Hospital Mass General
Start Date
2014-06-06
Trial ID
NCT02108964
Treatments Being Tested
The purpose of this study was to determine the maximum tolerated dose (MTD)...
Status
Terminated
Location
Massachusetts General Hospital Mass General
Start Date
2015-01-13
Trial ID
NCT02335944
Treatments Being Tested